Drug Approval Package
-
Gleevec (Imatinib Mesylate) Capsules
Company: Novartis Pharmaceuticals Corporation
Application No.: 21-335/S1
Approval Date: 2/1/2002
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Chemistry Review(s) (PDF)
-
Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
- Part 1 (PDF)
- Part 2 (PDF)
-
Correspondence (PDF)
Date created: July 08, 2003
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-